CT-P17: Clinical Trials

3 trials of CT-P17, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 31Completed 1

Follow CT-P17: new trials by email Literature Review of CT-P17 trials Research Report on CT-P17

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis
CT-P17, EU-approved Humira - Moderate to Severe Chronic Plaque Psoriasis
Phase 3CompletedCelltrion3672022-11-072024-08-21
To Compare the Pharmacokinetics and Safety of the Auto-injector and Pre-filled Syringe of CT-P17
CT-P17 - Healthy
Phase 1CompletedCelltrion1802019-06-212021-01-19
To Compare the Pharmacokinetics and Safety of CT-P17 and Humira in Healthy Subjects
CT-P17, US-licensed Humira, EU-approved Humira - Healthy
Phase 1CompletedCelltrion3122019-05-312021-11-18

Sponsors

Celltrion (3)

Countries

Estonia (1)  ·  South Korea (1)  ·  United States (1)

Top investigators

Sang Joon Lee (1)  ·  Sung Hyun Kim, Dr (1)

Results publications

PMID 33503313, PMID 33822406, PMID 39932677, PMID 40148673